在ANCA相关的间歇性肺病中临床概况,生存和肺功能结果:一项观察性研究
Cristina Valero-Martínez1, Claudia Valenzuela2, Juan Pablo Baldivieso Achá1
1Rheumatology Department, Hospital Universitario de La Princesa, IIS-Princesa, 28006 Madrid, Spain.
Journal of clinical medicine
|January 11, 2025
概括
与抗中性粒细胞质抗体 (ANCA) 相关的间歇性肺病 (ILD) 经常呈现纤维化模式,近一半的患者患有与ANCA相关的血管炎 (AAV). 早期死亡率很高,这强调了所有ILD患者需要ANCA测试的必要性.
科学领域:
- 肺部病理学 肺部病理学
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
背景情况:
- 抗中性粒细胞质抗体 (ANCA) 越来越多地检测到间歇性肺病 (ILD).
- 在ILD中ANCA的预后影响,特别是在没有明显的ANCA相关血管炎 (AAV) 的情况下,仍然不清楚.
- 目前,ANCA不是具有自身免疫特征的间歇性肺炎 (IPAF) 标准的一部分,这可能导致诊断不足.
研究的目的:
- 调查ANCA阳性ILD患者的临床特征和预后.
- 为了确定ANCA-ILD患者中AAV的流行率.
- 在ANCA-ILD.中确定与肺功能下降和死亡率相关的因素.
主要方法:
- 对23名ILD患者具有阳性ANCA的单中心队列的回顾分析.
- 评估肺功能,放射学模式,血清学标志物和治疗反应.
- 使用卡普兰-梅尔曲线和考克斯回归模型进行生存分析.
主要成果:
- 该队列主要由女性组成,中位数为ILD诊断后36个月. 抗MPO抗体是最常见的 (56.5%).
- 几乎一半的患者 (47.8%) 患有并发性AAV,主要是微观多炎 (MPA),与抗MPO和NSIP模式相关.
- 纤维化模式 (UIP或纤维化NSIP) 是普遍存在的 (73.9%),特别是UIP (51.2%). 观察到高累积死亡率 (43.4%),UIP模式与增加的早期死亡率有关.
- 肺功能受损或放射性进展发生在65.2%的患者中. 免疫抑制剂的使用显示出减少ILD相关死亡的趋势.
结论:
- ANCA-ILD患者经常表现出纤维化肺病,并且很大一部分患者有相关的AAV.
- 这个队列中高和早期的死亡率凸显了ANCA在ILD中的临床意义.
- 建议在所有ILD患者中进行常规ANCA测试,以改善诊断和管理.
相关概念视频
COPD: Pathogenesis and Clinical Features
230
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
230
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328


